One of the main activities of SAU is the development of public health guidance and risk assessment on infectious disease prevention and control, e.g. guidance on human papilloma vaccination, rapid risk assesment on a new strain of seasonal H1N1 influenza resistant to oseltamivir (Tamiflu), or scientific opinion on the use of influenza H5N1 vaccines for humans.
Ena od glavnih dejavnosti Enote za znanstveno svetovanje je razvoj smernic za javno zdravstvo in ocene tveganja za preprečevanje in obvladovanje nalezljivih bolezni, npr. smernic za cepljenje proti humanemu papiloma virusu, hitre ocene tveganja zaradi novega seva sezonske gripe H1N1, ki je odporen proti oseltamiviru (Tamiflu), ali znanstvenega mnenja o uporabi cepiv proti gripi H5N1 pri ljudeh.